Analyst Consensus ?
ConsensusBuy22 ratings
Bullish1881.8%
Neutral418.2%
Bearish00.0%
FN2 Earnings Intelligence
Ares Management Corporation (ARES) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Oppenheimer | Outperform | Outperform | Maintain | Jul 17, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Jul 13, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Jul 9, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 9, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jun 23, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Apr 28, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Apr 21, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 7, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Feb 24, 2026 |
| Raymond James | Strong Buy | Market Perform | Upgrade | Feb 9, 2026 |
| Deutsche Bank | Buy | Hold | Upgrade | Feb 9, 2026 |
| UBS | Neutral | Neutral | Maintain | Jan 13, 2026 |
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | Nov 4, 2025 |
| B of A Securities | Buy | Buy | Maintain | Oct 3, 2025 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Aug 6, 2025 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 11, 2025 |
| Jefferies | Hold | Hold | Maintain | May 9, 2024 |
| Piper Sandler | Overweight | Overweight | Maintain | Feb 13, 2023 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Nov 25, 2020 |
| Keefe Bruyette & Woods | Outperform | Outperform | Maintain | Nov 25, 2020 |
| Credit Suisse | Outperform | Neutral | Upgrade | Nov 25, 2020 |
| Bank of America | Buy | Neutral | Upgrade | Nov 25, 2020 |
Upside is calculated against the persisted current price $124.6. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Morgan Stanley | Analyst unavailable | $160 | $121.14 | +28.4% | Jul 21, 2026 |
| BMO Capital | Analyst unavailable | $128 | $122.06 | +2.7% | Jul 13, 2026 |
| Barclays | Analyst unavailable | $139 | $120.29 | +11.6% | Jul 9, 2026 |
| Barclays | Analyst unavailable | $140 | $119.06 | +12.4% | May 4, 2026 |
| Morgan Stanley | Analyst unavailable | $163 | $122.32 | +30.8% | Apr 21, 2026 |
| RBC Capital | Bart Dziarski | $173 | $115.94 | +38.8% | Feb 24, 2026 |
| UBS | Analyst unavailable | $148 | $128.16 | +18.8% | Feb 20, 2026 |
| RBC Capital | Analyst unavailable | $180 | $135.12 | +44.5% | Feb 9, 2026 |
| Oppenheimer | Analyst unavailable | $215 | $128.94 | +72.6% | Feb 6, 2026 |
| Goldman Sachs | Analyst unavailable | $165 | $128.7 | +32.4% | Feb 6, 2026 |
| Barclays | Analyst unavailable | $190 | $121.87 | +52.5% | Feb 6, 2026 |
| Deutsche Bank | Brian Bedell | $155 | $121.87 | +24.4% | Feb 6, 2026 |
| Morgan Stanley | Analyst unavailable | $178 | $149.69 | +42.9% | Jan 27, 2026 |
| Oppenheimer | Analyst unavailable | $224 | $167.03 | +79.8% | Jan 20, 2026 |
| UBS | Analyst unavailable | $198 | $169.5 | +58.9% | Jan 13, 2026 |
| Barclays | Analyst unavailable | $222 | $175.75 | +78.2% | Jan 9, 2026 |
| Wolfe Research | Analyst unavailable | $210 | $172.84 | +68.5% | Jan 7, 2026 |
| Barclays | Analyst unavailable | $218 | $176.82 | +75.0% | Dec 12, 2025 |
| UBS | Michael Brown | $201 | $178.3 | +61.3% | Dec 11, 2025 |
| Oppenheimer | Chris Kotowski | $190 | $153.75 | +52.5% | Nov 4, 2025 |
| Morgan Stanley | Analyst unavailable | $175 | $149.21 | +40.4% | Oct 21, 2025 |
| Oppenheimer | Analyst unavailable | $180 | $143.63 | +44.5% | Oct 14, 2025 |
| Barclays | Analyst unavailable | $187 | $148.64 | +50.1% | Oct 8, 2025 |
| JMP Securities | Brian McKenna | $195 | $180.34 | +56.5% | Jul 14, 2025 |
| Wolfe Research | Steven Chubak | $193 | $159.63 | +54.9% | May 6, 2025 |
| Barclays | Benjamin Budish | $182 | $160.96 | +46.1% | May 6, 2025 |
| Wolfe Research | Steven Chubak | $218 | $180.87 | +75.0% | Jan 3, 2025 |
| RBC Capital | Kenneth Lee | $205 | $176.11 | +64.5% | Dec 10, 2024 |
| RBC Capital | Kenneth Lee | $170 | $157.81 | +36.4% | Oct 11, 2024 |
| Morgan Stanley | Michael Cyprys | $162 | $156.95 | +30.0% | Oct 10, 2024 |
| Barclays | Benjamin Budish | $174 | $160.39 | +39.6% | Oct 7, 2024 |
| CFRA | Kenneth Leon | $170 | $156.38 | +36.4% | Sep 23, 2024 |
| Wells Fargo | Michael Brown | $156 | $141.46 | +25.2% | Sep 11, 2024 |
| Redburn Partners | Nicholas Watts | $140 | $146.96 | +12.4% | Aug 27, 2024 |
| Barclays | Benjamin Budish | $155 | $139.26 | +24.4% | Aug 5, 2024 |
| CFRA | Kenneth Leon | $155 | $139.26 | +24.4% | Aug 2, 2024 |
| Barclays | Benjamin Budish | $151 | $134.78 | +21.2% | Jul 10, 2024 |
| Deutsche Bank | Brian Bedell | $132 | $137.49 | +5.9% | Jun 13, 2024 |
| Deutsche Bank | Brian Bedell | $176 | $146.7 | +41.3% | May 28, 2024 |
| UBS | Brent Dilts | $160 | $146.31 | +28.4% | May 22, 2024 |
| RBC Capital | Kenneth Lee | $150 | $136.17 | +20.4% | May 7, 2024 |
| Barclays | Benjamin Budish | $150 | $134.64 | +20.4% | May 3, 2024 |
| Barclays | Analyst unavailable | $87 | $75.1 | -30.2% | Jan 12, 2023 |
| Barclays | Analyst unavailable | $82 | $68.14 | -34.2% | Dec 19, 2022 |
| UBS | Analyst unavailable | $95 | $79.53 | -23.8% | Nov 15, 2022 |
| BMO Capital | Analyst unavailable | $87 | $68.79 | -30.2% | Apr 29, 2022 |
| Morgan Stanley | Analyst unavailable | $90 | $81.94 | -27.8% | Apr 20, 2022 |
| Wells Fargo | Analyst unavailable | $92 | $79.71 | -26.2% | Apr 19, 2022 |
| Barclays | Jeremy Campbell | $62 | $53.55 | -50.2% | Apr 12, 2021 |
Track every rating change on ARES the moment it posts. Free to start.
Start free